Trial intelligence / Profile preview

Pharmacokinetics and short-term safety of ciprofloxacin in neonates and young infants

2010-019955-23Phase 4Completed

Sponsor: Liverpool Women's NHS Foundation Trust
Start: Nov 2010
Modality: Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, open-label, single-arm trial of ciprofloxacin in sepsis and Gram-negative bacterial infection, sponsored by Liverpool Women's NHS Foundation Trust. Primary endpoints: Population pharmacokinetic model of ciprofloxacin and Tolerability and short-term safety of ciprofloxacin. Started Nov 2010; status: completed.

Drugs

ciprofloxacin

Conditions

sepsisGram-negative bacterial infection

Beyond the preview

Go deeper on 2010-019955-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019955-23.